The Current Ratio as of November 2024 (TTM) for PureTech Health plc (PRTC) is 3.68

According to PureTech Health plc’s latest financial reports and current stock price. The company's current Current Ratio is 3.68. This represents a change of -29.51% compared to the average of 5.22 of the last 4 quarters.

PureTech Health plc (PRTC) Historical Current Ratio (quarterly & annually)

How has PRTC Current Ratio performed in the past?

The mean historical Current Ratio of PureTech Health plc over the last ten years is 2.40. The current 3.68 Current Ratio has changed 15.26% with respect to the historical average. Over the past ten years (40 quarters), PRTC's Current Ratio was at its highest in in the March 2023 quarter at 7.31. The Current Ratio was at its lowest in in the March 2019 quarter at 0.69.

PureTech Health plc (PRTC) Current Ratio by Quarter and Year

Discovering the peaks and valleys of PureTech Health plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

PureTech Health plc (PRTC) Average Current Ratio

How has PRTC Current Ratio performed in the past?

The current Current Ratio of PureTech Health plc (PRTC) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

PureTech Health plc (PRTC) Current Ratio vs. Peers

How is PRTC’s Current Ratio compared to its peers?

PureTech Health plc’s Current Ratio is less than Molecular Partners AG (14.33), less than MediciNova, Inc. (16.66), greater than Anebulo Pharmaceuticals, Inc. (3.45), greater than Champions Oncology, Inc. (0.69), less than Cyteir Therapeutics, Inc. (21.89), less than Eliem Therapeutics, Inc. (60.41), greater than Opthea Limited (2.94), less than Acrivon Therapeutics, Inc. Common Stock (12.75), less than Mineralys Therapeutics, Inc. (8.55), less than Janux Therapeutics, Inc. (38.80), less than Rezolute, Inc. (13.79), less than Nuvation Bio Inc. (9.57), less than Magenta Therapeutics, Inc. (14.64), less than Neoleukin Therapeutics, Inc. (15.33), less than Graphite Bio, Inc. (11.47),

Build a custom stock screener for PureTech Health plc (PRTC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PureTech Health plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PureTech Health plc (PRTC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PureTech Health plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.